Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

View ORCID ProfileAB Docherty, View ORCID ProfileEM Harrison, View ORCID ProfileCA Green, View ORCID ProfileH Hardwick, View ORCID ProfileR Pius, View ORCID ProfileL Norman, View ORCID ProfileKA Holden, View ORCID ProfileJM Read, View ORCID ProfileF Dondelinger, View ORCID ProfileG Carson, View ORCID ProfileL Merson, View ORCID ProfileJ Lee, View ORCID ProfileD Plotkin, View ORCID ProfileL Sigfrid, View ORCID ProfileS Halpin, C Jackson, View ORCID ProfileC Gamble, View ORCID ProfilePW Horby, View ORCID ProfileJS Nguyen-Van-Tam, ISARIC4C Investigators, View ORCID ProfileJ Dunning, View ORCID ProfilePJM Openshaw, View ORCID ProfileJK Baillie, View ORCID ProfileMG Semple
doi: https://doi.org/10.1101/2020.04.23.20076042
AB Docherty
1Centre for Medical Informatics, The Usher Institute, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for AB Docherty
EM Harrison
1Centre for Medical Informatics, The Usher Institute, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for EM Harrison
CA Green
2Institute of Microbiology & Infection, University of Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for CA Green
H Hardwick
3NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool
4Institute of Infection and Global Health, Faculty of Health and Life Sciences, University of Liverpool
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H Hardwick
R Pius
1Centre for Medical Informatics, The Usher Institute, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R Pius
L Norman
1Centre for Medical Informatics, The Usher Institute, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L Norman
KA Holden
5Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for KA Holden
JM Read
6Centre for Health Informatics, Computing and Statistics, Lancaster Medical School, Lancaster University, Bailrigg, United Kingdom LA1 4YG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for JM Read
F Dondelinger
6Centre for Health Informatics, Computing and Statistics, Lancaster Medical School, Lancaster University, Bailrigg, United Kingdom LA1 4YG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F Dondelinger
G Carson
7ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G Carson
L Merson
7ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford
8Infectious Diseases Data Observatory (IDDO), Centre for Tropical Medicine and Global Health, University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L Merson
J Lee
7ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Lee
D Plotkin
7ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D Plotkin
L Sigfrid
7ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L Sigfrid
S Halpin
9Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S Halpin
C Jackson
9Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Gamble
9Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C Gamble
PW Horby
10Centre for Tropical Medicine and International Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for PW Horby
JS Nguyen-Van-Tam
11Division of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for JS Nguyen-Van-Tam
J Dunning
12National Infection Service, Public Health England, 61 Colindale Ave, London, NW9 5EQ
13Faculty of Medicine, Imperial College London, Norfolk Place, London, W2 1PG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Dunning
PJM Openshaw
14National Heart and Lung Division, Faculty of Medicine, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for PJM Openshaw
JK Baillie
15Roslin Institute, University of Edinburgh, Edinburgh, UK
16Intensive Care Unit, Royal Infirmary Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for JK Baillie
MG Semple
17NIHR Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool
18Alder Hey Children’s Hospital, Liverpool
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for MG Semple
  • For correspondence: m.g.semple@liverpool.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Structured abstract

Objective To characterize the clinical features of patients with severe COVID-19 in the UK.

Design Prospective observational cohort study with rapid data gathering and near real-time analysis, using a pre-approved questionnaire adopted by the WHO.

Setting 166 UK hospitals between 6th February and 18th April 2020.

Participants 16,749 people with COVID-19.

Interventions No interventions were performed, but with consent samples were taken for research purposes. Many participants were co-enrolled in other interventional studies and clinical trials.

Results The median age was 72 years [IQR 57, 82; range 0, 104], the median duration of symptoms before admission was 4 days [IQR 1,8] and the median duration of hospital stay was 7 days [IQR 4,12]. The commonest comorbidities were chronic cardiac disease (29%), uncomplicated diabetes (19%), non-asthmatic chronic pulmonary disease (19%) and asthma (14%); 47% had no documented reported comorbidity. Increased age and comorbidities including obesity were associated with a higher probability of mortality. Distinct clusters of symptoms were found: 1. respiratory (cough, sputum, sore throat, runny nose, ear pain, wheeze, and chest pain); 2. systemic (myalgia, joint pain and fatigue); 3. enteric (abdominal pain, vomiting and diarrhoea). Overall, 49% of patients were discharged alive, 33% have died and 17% continued to receive care at date of reporting. 17% required admission to High Dependency or Intensive Care Units; of these, 31% were discharged alive, 45% died and 24% continued to receive care at the reporting date. Of those receiving mechanical ventilation, 20% were discharged alive, 53% died and 27% remained in hospital.

Conclusions We present the largest detailed description of COVID-19 in Europe, demonstrating the importance of pandemic preparedness and the need to maintain readiness to launch research studies in response to outbreaks.

Trial documentation Available at https://isaric4c.net/protocols. Ethical approval in England and Wales (13/SC/0149), and Scotland (20/SS/0028). ISRCTN (pending).

Competing Interest Statement

AB Docherty reports grants from Department of Health and Social Care, during the conduct of the study; grants from Wellcome Trust, outside the submitted work; CA Green reports grants from DHSC National Institute of Health Research UK, during the conduct of the study; F Dondelinger is due to start a position at F. Hoffmann - La Roche on 4th May 2020; PW Horby reports grants from Wellcome Trust / Department for International Development / Bill and Melinda Gates Foundation, grants from NIHR, during the conduct of the study; JS Nguyen-Van-Tam reports grants from Department of Health and Social Care, England, during the conduct of the study; and is seconded to the Department of Health and Social Care, England (DHSC); PJM Openshaw reports personal fees from Consultancy, grants from MRC, grants from EU Grant, grants from NIHR Biomedical Research Centre, grants from MRC/GSK, grants from Wellcome Trust, grants from NIHR (HPRU), grants from NIHR Senior Investigator, personal fees from European Respiratory Society, grants from MRC Global Challenge Research Fund, outside the submitted work; and The role of President of the British Society for Immunology was an unpaid appointment but travel and accommodation at some meetings is provided by the Society; JK Baille reports grants from Medical Research Council UK; MG Semple reports grants from DHSC National Institute of Health Research UK, grants from Medical Research Council UK, grants from Health Protection Research Unit in Emerging & Zoonotic Infections, University of Liverpool, during the conduct of the study; other from Integrum Scientific LLC, Greensboro, NC, USA, outside the submitted work. EM Harrison, H Ardwick, J Dunning, R Pius, L Norman, KA Holden, JM Read, G Carson, L Merson, J Lee, D Plotkin, L Sigfred, S Halpin, C Jackson, C Gamble, have nothing to declare.

Clinical Trial

ISRCTN pending

Clinical Protocols

https://isaric4c.net/protocols

Funding Statement

This work is supported by grants from: the National Institute for Health Research [award CO-CIN-01], the Medical Research Council [grant MC_PC_19059] and by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford [NIHR award 200907], Wellcome Trust and Department for International Development [215091/Z/18/Z], and the Bill and Melinda Gates Foundation [OPP1209135], and Liverpool Experimental Cancer Medicine Centre for providing infrastructure support for this research (Grant Reference: C18616/A25153). JSN-V-T is seconded to the Department of Health and Social Care, England (DHSC). The views expressed are those of the authors and not necessarily those of the DHSC, DID, NIHR, MRC, Wellcome Trust or PHE.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† ISARIC4C Investigators listed below

  • Annemarie B. Docherty, Annemarie.docherty{at}ed.ac.uk, Centre for Medical Informatics, The Usher Institute, University of Edinburgh

    Ewen M Harrison, ewen.harrison{at}ed.ac.uk, Centre for Medical Informatics, Usher Institute, University of Edinburgh

    Christopher A. Green, c.a.green.2{at}bham.ac.uk, Institute of Microbiology & Infection, University of Birmingham

    Hayley Hardwick, h.e.hardwick{at}liverpool.ac.uk, NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, and Institute of Infection and Global Health, Faculty of Health and Life Sciences, University of Liverpool.

    Riinu Pius, r.ots{at}ed.ac.uk, Centre for Medical Informatics, Usher Institute, University of Edinburgh

    Lisa Norman, lisa.norman{at}ed.ac.uk, Centre for Medical Informatics, Usher Institute, University of Edinburgh

    Karl A Holden, Karl.Holden{at}liverpool.ac.uk, Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool.

    Jonathan Read, jonathan.read{at}lancaster.ac.uk Centre for Health Informatics, Computing and Statistics, Lancaster Medical School, Lancaster University, Bailrigg, United Kingdom LA1 4YG

    Frank Dondelinger, f.dondelinger{at}lancaster.ac.uk, Centre for Health Informatics, Computing and Statistics, Lancaster Medical School, Lancaster University, Bailrigg, United Kingdom LA1 4YG

    Gail Carson, gail.carson{at}ndm.ox.ac.uk, ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford

    Laura Merson laura.merson{at}ndm.ox.ac.uk Infectious Diseases Data Observatory (IDDO), Centre for Tropical Medicine and Global Health, University of Oxford, UK

    Laura Merson ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford laura.merson{at}ndm.ox.ac.uk

    James Lee, ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford E-mail: james.lee{at}ndm.ox.ac.uk

    Daniel Plotkin, ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK E-mail: daniel.plotkin{at}ndm.ox.ac.uk

    Louise Sigfrid, ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford louise.sigfrid{at}ndm.ox.ac.uk

    Sophie Halpin, Liverpool Clinical Trials Centre, University of Liverpool sophieh{at}liverpool.ac.uk

    Clare Jackson, Liverpool Clinical Trials Centre, University of Liverpool clarej{at}liverpool.ac.uk

    Carrol Gamble, Liverpool Clinical Trials Centre, University of Liverpool, c.gamble{at}liverpool.ac.uk

    Peter W. Horby peter.horby{at}ndm.ox.ac.uk, Centre for Tropical Medicine and International Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK

    Jonathan S. Nguyen-Van-Tam, Jonathan.Van-Tam{at}nottingham.ac.uk Division of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham UK

    Jake Dunning Jake.Dunning{at}phe.gov.uk National Infection Service, Public Health England, 61 Colindale Ave, London, NW9 5EQ and Faculty of Medicine, Imperial College London, Norfolk Place, London, W2 1PG

    Peter JM Openshaw p.openshaw{at}imperial.ac.uk National Heart and Lung Division, Faculty of Medicine, Imperial College London

    J Kenneth Baillie, Roslin Institute, University of Edinburgh, Edinburgh, UK and Intensive Care Unit, Royal Infirmary Edinburgh, UK j.k.baillie{at}ed.ac.uk

    Malcolm G Semple, m.g.semple{at}liverpool.ac.uk, NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, and Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool and Alder Hey Children’s Hospital, Liverpool.

  • The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in BMJ editions and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence.

  • Prof. Semple affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Data Availability

The protocol, revision history, case report form, information leaflets and consent forms and detail of the Independent Data and Material Access Committee (IDAMAC) are available at https://isaric4c.net.

https://isaric4c.net/protocols

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 28, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, KA Holden, JM Read, F Dondelinger, G Carson, L Merson, J Lee, D Plotkin, L Sigfrid, S Halpin, C Jackson, C Gamble, PW Horby, JS Nguyen-Van-Tam, ISARIC4C Investigators, J Dunning, PJM Openshaw, JK Baillie, MG Semple
medRxiv 2020.04.23.20076042; doi: https://doi.org/10.1101/2020.04.23.20076042
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, KA Holden, JM Read, F Dondelinger, G Carson, L Merson, J Lee, D Plotkin, L Sigfrid, S Halpin, C Jackson, C Gamble, PW Horby, JS Nguyen-Van-Tam, ISARIC4C Investigators, J Dunning, PJM Openshaw, JK Baillie, MG Semple
medRxiv 2020.04.23.20076042; doi: https://doi.org/10.1101/2020.04.23.20076042

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1240)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10023)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2281)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4834)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)